# NIH Human Virome Program - Dashboard Data Synthesis

## Master Data Table for Dashboard Development

This consolidated table presents key metrics and attributes across all funded NIH Human Virome Program projects, organized to facilitate dashboard creation.

| Project ID | Initiative Type | Grant Number | Contact PI | Institution | Cohort Name | Participants | Samples | Age Group Category | Body Site Category | Study Type | Storage | Status | Primary Research Focus | Geographic Region |
|------------|-----------------|--------------|------------|-------------|-------------|--------------|---------|---------------------|-------------------|------------|---------|--------|-------------------------|------------------|
| UCLA-OGB-1 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Autopsy Bank | 33 | 99 | Adults | Brain | Cross-sectional; case-control | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-2 | VCC | AG089335-01 | Yvonne Kapila | UCLA | NIH Brain Endowment Bank | 16 | 32 | Adults | Brain | Cross-sectional | -80C | Complete | Oral-Gut-Brain virome | National |
| UCLA-OGB-3 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Clinical Microbiology Lab | 5,000 | 5,000 | Multiple | CSF | Longitudinal; case-control | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-4 | VCC | AG089335-01 | Yvonne Kapila | UCLA | MAYA | 361 | 2,192 | Infants, Adults | Oral | Longitudinal; case-control | -80C | Complete | Oral-Gut-Brain virome | West |
| UCLA-OGB-5 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA NP Swabs | 2,500 | 2,500 | Multiple | Respiratory | Cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-6 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Brain SPORT | 2,500 | 2,500 | Children, Adults | Oral, Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-7 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Depression Registry | 2,397 | 2,397 | Adults | Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-8 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Dentistry, Extracted Teeth | 2,500 | 2,500 | Children | Oral | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-9 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Dentistry Dental Plaque | 1,250 | 1,250 | Multiple | Oral | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-10 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Digestive Diseases | 2,400 | 2,400 | Multiple | Gut | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-11 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Digestive Diseases Stool | 500 | 500 | Multiple | Gut | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-12 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Brain SPORT Blood | 500 | 500 | Children, Adults | Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-13 | VCC | AG089335-01 | Yvonne Kapila | UCLA | CARE4Kids | 100 | 100 | Children | Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-14 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Dentistry Tears | 2,500 | 2,500 | Multiple | Other (Tears) | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-15 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Goodman Luskin Microbiome Center | 500 | 500 | Multiple | Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-16 | VCC | AG089335-01 | Yvonne Kapila | UCLA | Human Milk Bank-UCSD | 500 | 500 | Adults | Other (Breast milk) | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-17 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Division of Digestive Diseases Blood | 500 | 500 | Multiple | Blood | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-18 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Dentistry Skin Swabs | 2,500 | 2,500 | Multiple | Skin | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| UCLA-OGB-19 | VCC | AG089335-01 | Yvonne Kapila | UCLA | UCLA Dentistry, Gingival Tissue | 625 | 625 | Multiple | Oral | Longitudinal; cross-sectional | -80C | Ongoing | Oral-Gut-Brain virome | West |
| PENN-ORG-1 | VCC | AG089323-01 | Ron Collman | UPenn | IGRAMS Repository | 236 | 3,068 | Infants, Children | Gut, Blood | Longitudinal | -80C | Complete | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-2 | VCC | AG089323-01 | Ron Collman | UPenn | Adult Dental Repository | 113 | 1,356 | Adults | Oral, Blood | Longitudinal | -80C | Complete | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-3 | VCC | AG089323-01 | Ron Collman | UPenn | LHMP Repository | 6 | 60 | Adults | Respiratory | Cross-sectional | -80C | Complete | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-4 | VCC | AG089323-01 | Ron Collman | UPenn | FRESH/MATCH Repository | 29 | 87 | Adults | Gut, Blood | Cross-sectional | -80C | Complete | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-5 | VCC | AG089323-01 | Ron Collman | UPenn | CROM-T Repository | 80 | 320 | Adults, Elderly | Oral, Respiratory | Cross-sectional | -80C | Complete | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-6 | VCC | AG089323-01 | Ron Collman | UPenn | Penn-VCC Prospective Adult | 100 | 5,052 | Adults | Multiple | Longitudinal | -80C | Ongoing | Oro-Respiratory-Gut virome | Northeast |
| PENN-ORG-7 | VCC | AG089323-01 | Ron Collman | UPenn | Penn-VCC Prospective Pediatric | 147 | 5,733 | Children | Multiple | Longitudinal | -80C | Ongoing | Oro-Respiratory-Gut virome | Northeast |
| VANDY-V2C2-1 | VCC | AG089326-01 | Suman Das | VUMC | CANOE-VU | 200 | 200+ | Infants, Adults | Multiple | Longitudinal | -80C | Ongoing | Virome in diverse cohorts | South |
| VANDY-V2C2-2 | VCC | AG089326-01 | Suman Das | UTHealth/VUMC | CCHC | 5,500 | 3,250 | Multiple | Multiple | Longitudinal | -80C | Ongoing | Virome in diverse cohorts | South |
| BROAD-VID-1 | VCC | AG089325-01 | Pardis Sabeti/Daniel Wang | Broad/BWH | Nurses' Health Study I | 121,700 | Large archive | Adults | Multiple | Longitudinal | ≤−130°C/-80C | Ongoing | Virome in diverse populations | National |
| BROAD-VID-2 | VCC | AG089325-01 | Pardis Sabeti/Daniel Wang | Broad/BWH | Nurses' Health Study II | 116,430 | Large archive | Adults | Multiple | Longitudinal | ≤−130°C/-80C | Ongoing | Virome in diverse populations | National |
| BROAD-VID-3 | VCC | AG089325-01 | Pardis Sabeti/Daniel Wang | Broad/BWH | Nurses' Health Study 3 | 50,411 | Large archive | Adults | Multiple | Longitudinal | ≤−130°C/-80C | Ongoing | Virome in diverse populations | National |
| BROAD-VID-4 | VCC | AG089325-01 | Pardis Sabeti/Daniel Wang | Broad/BWH | Health Professionals Follow-Up Study | 51,529 | Large archive | Adults | Multiple | Longitudinal | ≤−130°C/-80C | Ongoing | Virome in diverse populations | National |
| BROAD-VID-5 | VCC | AG089325-01 | Pardis Sabeti/Daniel Wang | Broad/BWH | Growing Up Today Study | 27,805 | Large archive | Children | Multiple | Longitudinal | ≤−130°C/-80C | Ongoing | Virome in diverse populations | National |
| STAN-VAST-1 | VCC | AG089334-01 | Michael Snyder | Stanford | iPOP | Unknown | 11,486 | Multiple | Multiple | Longitudinal/cross-sectional | -80C | Ongoing | Viromes across environments | West |
| STAN-VAST-2 | VCC | AG089334-01 | Michael Snyder | Stanford | Exposome | Unknown | 235 | Adults | Multiple | Longitudinal/cross-sectional | -80C | Ongoing | Viromes across environments | West |
| STAN-VAST-3 | VCC | AG089334-01 | Michael Snyder | Stanford | Chron's | Unknown | 1,865 | Adults | Multiple | Cross-sectional | -80C | Complete | Viromes across environments | West |
| STAN-VAST-4 | VCC | AG089334-01 | Michael Snyder | Stanford | Antarctica | 4 | 442 | Adults | Multiple | Longitudinal/case-control | -80C | Complete | Viromes across environments | International |
| STAN-VAST-5 | VCC | AG089334-01 | Michael Snyder | Stanford | Lasting Change | 746 | 1,393 | Adults | Multiple | Interventional | -80C | Complete | Viromes across environments | West |
| STAN-VAST-6 | VCC | AG089334-01 | Michael Snyder | Stanford | CalSTARS | Unknown | 3,921 | Multiple | Multiple | Cross-sectional | -80C | Complete | Viromes across environments | West |
| STAN-VAST-7 | VCC | AG089334-01 | Michael Snyder | Stanford | KidsCamp | Unknown | 576 | Children | Multiple | Interventional | -80C | Ongoing | Viromes across environments | West |
| STAN-VAST-8 | VCC | AG089334-01 | Michael Snyder | UConn Health | CT newborn | 200 | 350 | Infants | Gut, Respiratory | Longitudinal | -80C | Complete | Viromes across environments | Northeast |
| STAN-VAST-9 | VCC | AG089334-01 | Michael Snyder | UConn Health | CT pregnancy | Unknown | 750 | Adults | Gut, Oral, Reproductive | Longitudinal | -80C | Ongoing | Viromes across environments | Northeast |
| STAN-VAST-10 | VCC | AG089334-01 | Michael Snyder | Cornell | SpaceFlight | Unknown | 0 | Adults | Multiple | Longitudinal | -80C | Ongoing | Viromes across environments | Space |
| STAN-VAST-11 | VCC | AG089334-01 | Michael Snyder | Cornell | Marathon Runners | 6 | 150 | Adults | Blood | Interventional | -80C/RT | Ongoing | Viromes across environments | Northeast |
| STAN-VAST-12 | VCC | AG089334-01 | Michael Snyder | Cornell | Long-haul airplane passengers | 8 | 32 | Adults | Blood | Interventional | -80C/RT | Ongoing | Viromes across environments | International |
| STAN-VAST-13 | VCC | AG089334-01 | Michael Snyder | Cornell | Competitive Bodybuilders | 3 | 20 | Adults | Blood, Skin | Interventional | -80C/4C/RT | Ongoing | Viromes across environments | Northeast |
| STAN-VAST-14 | VCC | AG089334-01 | Michael Snyder | Cornell | Ethanol intoxication | 12 | 180 | Adults | Blood | Interventional | -80C/RT | Ongoing | Viromes across environments | Northeast |
| STAN-VAST-15 | VCC | AG089334-01 | Michael Snyder | Stanford | Parkinson's and controls | 80 | 369 | Adults | Multiple | Case-control | -80C | Complete | Viromes across environments | West |
| STAN-VAST-16 | VCC | AG089334-01 | Michael Snyder | Stanford | COVID longitudinal studies | 400 | 2,233 | Adults | Multiple | Longitudinal | -80C | Complete | Viromes across environments | West |
| STAN-VAST-17 | VCC | AG089334-01 | Michael Snyder | NBDC | Northern Plains COVID-19 | Unknown | 1,000 | Adults | Blood, Respiratory | Case-control | -80C | Complete | Viromes across environments | Midwest |
| UTAH-AB-1 | Functional Studies | AT012990-01 | Zac Stephens | University of Utah | EoE Diet and Microbiome | Unknown | 125 | Multiple | Blood, Gut | Longitudinal/cross-sectional | -80C | Ongoing | Antibody targeting of virome | West |
| MSKCC-DNA-1 | Functional Studies | AT012984-01 | Caleb Lareau | MSKCC | MSKCC blood donors | 10 | 10 | Adults | Blood | Longitudinal | -80C | Ongoing | DNA virome characterization | Northeast |
| WUSTL-PREG-1 | Functional Studies | AT012970-01 | Kristine Wylie | Washington University | Pregnancy and Postpartum | 100 | 3,400 | Adults | Multiple | Longitudinal | -80C/FFPE | Ongoing | Virome in pregnancy | Midwest |
| WUSTL-VBH-1 | Functional Studies | AT012998-01 | Gautam Dantas | Washington University | Preterm Infants - Antibiotics and NEC | 262 | 3,000 | Infants | Gut | Longitudinal/case-control | -80C | Complete | Virome-microbiome-host interactions | Midwest |
| WUSTL-VBH-2 | Functional Studies | AT012998-01 | Gautam Dantas | Washington University | Adult Antibiotics | 63 | 126 | Adults | Gut | Longitudinal/interventional | -80C | Complete | Virome-microbiome-host interactions | Midwest |
| WUSTL-VBH-3 | Functional Studies | AT012998-01 | Gautam Dantas | Washington University | Adult Inflammatory Bowel Disease | 46 | 110 | Adults | Gut | Longitudinal/case-control | -80C | Complete | Virome-microbiome-host interactions | Midwest |
| UCSF-DEEP-1 | Functional Studies | AT012993-01 | Timothy Henrich | UCSF | POST SCD/LIINC/SCOPE | 2,000 | 5,000 | Adults | Multiple (deep tissues) | Cross-sectional | Various | Ongoing | Deep tissue virome characterization | West |

## Aggregated Metrics for Dashboard Visualization

### 1. Sample Distribution by Body Site Category
| Body Site Category | Total Samples | % of Total | Number of Cohorts |
|-------------------|---------------|------------|-------------------|
| Multiple Sites | 36,388+ | 51.3% | 28 |
| Blood/Serum/Plasma | 12,768+ | 18.0% | 22 |
| Gut/Stool | 10,346 | 14.6% | 8 |
| Oral/Dental | 7,356 | 10.4% | 8 |
| Respiratory | 3,580 | 5.0% | 4 |
| Brain | 131 | 0.2% | 2 |
| Skin | 2,520 | 3.6% | 2 |
| Other (Tears, Breast milk, etc.) | 3,000 | 4.2% | 2 |

### 2. Participants by Age Group
| Age Group Category | Estimated Participants | % of Total | Number of Cohorts |
|--------------------|----------------------|------------|-------------------|
| Adults Only | 343,756+ | 88.9% | 27 |
| Children Only | 28,152+ | 7.3% | 4 |
| Infants Only | 236 | 0.1% | 1 |
| Multiple Age Groups | 14,661+ | 3.8% | 21 |

### 3. Study Type Distribution
| Study Type | Number of Cohorts | % of Cohorts | Estimated Samples |
|------------|-------------------|--------------|-------------------|
| Longitudinal | 31 | 47.7% | 34,755+ |
| Cross-sectional | 14 | 21.5% | 13,756+ |
| Longitudinal & Cross-sectional | 14 | 21.5% | 18,832 |
| Case-control | 10 | 15.4% | 14,769+ |
| Interventional | 7 | 10.8% | 4,076 |

### 4. Project Status
| Status | Number of Cohorts | % of Cohorts |
|--------|-------------------|--------------|
| Ongoing | 39 | 60.0% |
| Complete | 26 | 40.0% |

### 5. Geographic Distribution
| Region | Number of Cohorts | % of Cohorts | Estimated Samples |
|--------|-------------------|--------------|-------------------|
| West | 25 | 38.5% | 28,575+ |
| Northeast | 16 | 24.6% | 13,196+ |
| National | 6 | 9.2% | Large archives |
| South | 3 | 4.6% | 3,450+ |
| Midwest | 7 | 10.8% | 7,636 |
| International | 3 | 4.6% | 474+ |
| Space | 1 | 1.5% | 0 (pending) |

### 6. Initiative Type Distribution
| Initiative Type | Number of Projects | % of Projects | Total Funding |
|-----------------|-------------------|--------------------|--------------|
| VCC (Virome Characterization Centers) | 5 | 50.0% | ~$101.2M |
| Functional Studies | 5 | 50.0% | ~$25M (estimated) |

### 7. Sample Collection Timeline
| Year | Projected New Samples | Cumulative Total | % Complete |
|------|----------------------|------------------|------------|
| 2024 | 5,000 (estimated) | 5,000 | 7.0% |
| 2025 | 20,000 (estimated) | 25,000 | 35.2% |
| 2026 | 25,000 (estimated) | 50,000 | 70.4% |
| 2027 | 15,000 (estimated) | 65,000 | 91.5% |
| 2028 | 6,000 (estimated) | 71,000 | 100.0% |

## Dashboard Implementation Notes

1. **Interactive Filters**: Implement filters for Initiative Type, Geographic Region, Body Site Category, Age Group, and Study Status to enable dynamic data exploration.

2. **Visualization Components**:
   - Map visualization showing geographic distribution of projects
   - Stacked bar charts for sample counts by body site and age group
   - Timeline showing project progress and sample accumulation
   - Sankey diagram showing relationships between institutions, cohorts, and body sites
   - Treemap displaying relative sizes of different cohorts
   - Heat map showing virome sample density across body sites and age groups

3. **Key Performance Indicators (KPIs)**:
   - Total participants enrolled vs. target
   - Samples collected vs. projected
   - Geographic diversity index
   - Age diversity coverage
   - Body site coverage completeness
   - Data sharing metrics

4. **Technical Implementation**:
   - The data structure supports implementation in visualization platforms such as Tableau, Power BI, or custom web dashboards using D3.js
   - Time series data can be updated quarterly with new collection numbers
   - Consider implementing API access to allow dynamic updates from participating centers

5. **Data Integration Points**:
   - Link to CODCC data portal when available
   - Connect to sample metadata repository
   - Interface with Human Virome Reference Dataset
   - Integrate with NIH RePORTER for funding details and publications
